IVF Services Market Insights, Strategies, and Future Growth Trajectories

The ivf services market size has grown rapidly in recent years. It will grow from $17.13 billion in 2023 to $19.07 billion in 2024 at a compound annual growth rate (CAGR) of 11.3%. The growth in the historic period can be attributed to increased increasing prevalence of pcos condition, increased cases of the premature ovarian failure, increasing rate of male infertility and insurance coverages to ivf procedures.

The ivf services market size is expected to see strong growth in the next few years. It will grow to $27.67 billion in 2028 at a compound annual growth rate (CAGR) of 9.7%. The growth in the forecast period can be attributed to rising infertility rate, technological developments regarding fertility treatment, growing adoption of ivf services to aid in pregnancy, rising number of same sex couples, increase in number of fertility clinics, rise in disposable income and late parenthood. Major trends in the forecast period include providing mitochondrial replacement therapies to potentially overcome genetic disorders, adopting new technologies like fertility freezing and provide and better solutions to people seeking for fertility treatments., offering pgt-a screening or testing program to potentially increase the chances of pregnancy, using artificial intelligence to reduce costs and time, implement blockchain based apps to curate data to their users and adopting advanced technologies such as time-lapse microscopy for safe, uninterrupted and constant embryo observation.

Market Overview -
IVF is a process of fertilization where an egg is combined with sperm outside the body, in vitro (in glass"). In vitro fertilization (IVF) is a sophisticated set of treatments intended to improve fertility, avoid genetic issues, and aid in child conception. It is used to address infertility.

Download Free Sample of Report -

https://www.thebusinessresearchcompany.com/sample.aspx?id=3348&type=smp

Rising Infertility Rates Drive Growth In The In Vitro Fertilization (IVF) Services Market
The rising infertility rate contributed to the growth of the in vitro fertilization IVF services market. Infertility is known as the inability to conceive within 12 months. According to the US Department of Health and Human Services, around 12 to 13 couples in 100 have a problem in conceiving. Moreover, according to the Indian Journal of Community Medicine, 15 to 20 million infertility cases are in India alone. The rising infertility rate made people resort to IVF services contributing to the growth of the market.

Competitive Landscape -
Major companies operating in the ivf services market report are Monash IVF Group, Virtus Health Limited, Chelsea and Westminster Hospital NHS Foundation Trust, Genea Limited, Boston IVF, IVF Spain, Morpheus Life Sciences Pvt. Ltd., Dünya IVF, Cardone Reproductive Medicine & Infertility LLC, Cloudnine Fertility, Sun Pharmaceuticals Industries Ltd, Cadila Healthcare Ltd, Trivector Origio Scientific, Lab IVF Asia Pte Ltd, LG Life Sciences, Bourn Hall Clinic, Southend Fertility, Indira IVF, Pearl Women Hospital & Yash IVF Center, Corion Fertility Clinic, Origin International Fertility Center, Apollo Hospitals Dhaka, Australian Concept Infertility Medical Center (ACIMC), Bahosi Fertility Centre, , Bloom Fertility and Healthcare, Bumrungrad International Hospital, Center for Advanced Reproductive Medicine and Infertility, CHA Fertility Center, United Family Healthcare, The New Hope Fertility Center, Melinda Hospital, Bocah Indonesia, Daya Medika, Clinique de la Muette, Klinikum Stuttgart, DRK Kliniken Berlin, University Medical Center Freiburg, CREATE Fertility, The Centre for Reproductive & Genetic Health, The Bridge Centre, Next Generation Clinic, UNICA Clinic - Prague, Repromeda s.r.o., MD Medical Group, Univfy, Progyny, Advantia Health, Maven Clinic, Future Family, Instituto de Fertilidad Humana, The Colombian Center for Fertility and Sterility, NMC Health, Dubai Gynecology and Fertility Centre, , New Life Medical Centre, Cairo Fertility Centre (Egypt), Queens Fertility Centre (Egypt), BPE Partners, Cleopatra Hospitals Group (CHG)

Enhancing IVF Success With The Role Of Platelet-Rich Plasma (PRP) In Addressing Recurrent Implantation Failures
Platelet-rich plasma (PRP) is the latest technique increasingly used for improving IVF success rate in patients with recurrent implantation failures. PRP is used alongside fertility treatments like IVF to improve egg quality, uterine lining thickness and endometrial receptivity, and the treatment is primarily for recurrent implantation failure over multiple IVF cycles. According to an article published by the Journal of Assisted Reproduction and Genetics, women treated with PRP experienced a significant improvement in Follicle-Stimulating Hormone (FSH), Anti-Müllerian Hormone (AMH), and Antral Follicle Count (AFC) and help improve fertility.

Browse Full Report @

https://www.thebusinessresearchcompany.com/report/ivf-services-global-market-report

Key Segments -

The ivf services market covered in this report is segmented -

1) By Cycle Type: Fresh IVF Cycles(Non-donor), Thawed IVF Cycles(Non-donor), Donor Egg IVF Cycles
2) By Service Provider: Fertility Clinics, Hospitals, Surgical Centers, Clinical Research Institutes
3) By End User: Fertility Clinics, Hospitals & Other Settings

Key highlights covered in the report -
1. Detailed market size forecast and historical data analysis
2. Key drivers influencing market growth
3. Identification of upcoming trends and potential opportunities in the market
4. Analysis of major players strategies, to understand competitive dynamics and market positioning
5. Evaluation of regional dynamics

Contact Us:
The Business Research Company
Europe: +44 207 1930 708
Asia: +91 88972 63534
Americas: +1 315 623 0293
Email: info@tbrc.info

Follow Us On:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
Twitter: https://twitter.com/tbrc_info
Facebook: https://www.facebook.com/TheBusinessResearchCompany
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Blog: https://blog.tbrc.info/
Healthcare Blog: https://healthcareresearchreports.com/
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

Want To Know More About The Business Research Company?

The Business Research Company (www.thebusinessresearchcompany.com) is a market intelligence firm that pioneers in company, market, and consumer research. Located globally, TBRC's consultants specialise in various industries including manufacturing, healthcare, financial services, chemicals, and technology.

Global Market Model - World's Most Comprehensive Database

The Business Research Company's flagship product, Global Market Model (www.thebusinessresearchcompany.com/global-market-model) is a market intelligence platform covering various macroeconomic indicators and metrics across 60 geographies and 27 industries. The Global Market Model covers multi-layered datasets which help its users assess supply-demand gaps

This release was published on openPR.